CONGENITAL VARICELLA

 

CONGENITAL VARICELLA

 

DEFINITION:

A contagious infectious disease caused by a DNA herpesvirus Varicella causing varicella embryopathy (VE) or varicella of the newborn (VON).

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • newborn
  • risk factors:
    • exposure to variclla

PATHOGENESIS:

1. Routes of Transmission

1. Neonatal

1. Antenatal (in utero)

  • 1. Primary Maternal Infection
    • present with VE (in utero infection)
    • incidence of varicella during pregnancy is 1-5/10,000 pregnancies
    • 25% vertical transplacental transmission rate
    • congenital malformations (VE) are noted in 2.2% of fetuses infected in the first 20 weeks of pregnancy (NEJM March 31, 1994)
  • 2. Perinatal

    • present with VON (perinatal infection)
    • if maternal varicella occurs 5-21 days prior to delivery, neonatal disease appears in the first 4 days with a good prognosis (due to protective maternal IgG)
    • if maternal varicella occurs 5 days prior delivery to 2 days after delivery, neonatal disease presents be-tween 5-10 days of age and is mild to severe with up to a 30% mortality rate

    3. Postnatal

    • infected postnatally by respiratory route
    • term infants at no higher risk than older children except in some seronegative infants less than 1 month of age
    • preterm infants are at increased risk due to a lack of placental varicella IgG transfer which usually occurs late in the 3rd trimester

    2. Childhood

    1. Horizontal Transmission

    • direct human-to-human contact
      • by direct contact with lesions
      • by airborne droplets

    2. Background

    • humans are the only source of infection
    • incubation period: 14-21 days (childhood), 9-15 days (neonatal)
    • secondary attack rate is 90%
    • immunity is lifelong
    • varicella rather than zoster is associated with transmission to the fetus or neonate
    • asymptomatic primary infection is rare but reinfection is not contagious until the last lesion has crusted

    CLINICAL FEATURES:

    1. Varicella Embryopathy (Congenital or Fetal Varicella Syndrome)

    1. Central Nervous System Manifestations

    • microcephaly
    • paralysis
    • psychomotor retardation
    • seizures

    2. Ocular Manifestations

    • cataracts
    • chorioretinitis
    • Horner's Syndrome
    • microphthalmia
    • nystagmus

    3. Musculoskeletal Manifestations

    • cicatrical dermatomal skin lesions and scarring
    • unilateral atrophy of a limb with scarring and paresis
    • rudimentary digits
    • high incidence of zoster in the first 10 years of life (also if perinatal- or postnatally-acquired)

     

    Note: Fetuses infected within the last 3 weeks of pregnancy may be mildly affected (few vesicular lesions) or severely affected with fever, hemorrhagic rash, pneumonia, and generalized necrotic lesions of the viscera

    2. Varicella of the Newborn (VON)

    1. Prodrome

    • poor feeding, slight fever, malaise
    • scarlatiniform or morbilliform rash

    2. Systemic

    • mild fever, malaise, poor feeding
    • generalized pruritic, vesicular rash

    3. Complications

    • meningoencephalitis
    • pneumonia, respiratory distress
    • pericarditis, endocarditits, myocarditis
    • hepatitis, pancreatitis
    • glomerulonephritis
    • Other - arthritis, acute myositis, bacterial superin-fection, purpura fulminans, Reye Syndrome, thrombocytopenia

    INVESTIGATIONS:

    1. Diagnostic

    1. Virology

    • isolate virus from vesicular fluid

    2. Serology

    • varicella-specific IgM in fetal blood samples

    3. Others

    • to detect varicella antigen or nucleic acid
      • Tzanck preparation - look for inclusion bodies
      • ELISA
      • counterimmunoelecrophoresis
      • immunofluorescence

    2. Imaging Studies

    1. CT (Head)

    • cortical and cerebellar atrophy
    • encephaloclastic lesions

    MANAGEMENT:

    1. Medical

    1. Acyclovir

    • 15 mg/kg IV tid for 7 days
    • indicated for moderate to severe cases
    • side effects:
      • neurotoxicity - lethargy, seizures, coma, agitation, jitteriness

    2. Varicella-zoster Immune Globulin (VZIG)

    • 125 units IM
    • indicated in infants:
      • born to mothers who developed varicella within 5 days before delivery or 2 days after delivery
      • at risk premature infants less than 28 weeks or less than 1000 grams in weight
      • exposed seronegative mothers (thought to prevent fetal or neonatal infection or teratogenesis)

     

     

     

    Pediatric Database - CONGENITAL VARICELLA

    Pediatric Organization - Pedbase [at] Gmail.com